major depressive disorder

Cartoon of businessmen standing around a broken target
Biotech

J&J ends phase 3 depression program over 'insufficient efficacy'

J&J has stopped development of aticaprant as an adjunctive treatment for major depressive disorder but will explore other development opportunities.
Nick Paul Taylor Mar 7, 2025 4:55am
A puzzle of the brain with one missing piece

Takeda regains home rights to depression drug from Neurocrine

Jan 28, 2025 4:16am
Baseball sitting in a glove against a dark background

After 3rd phase 3 strike, Relmada's depression drug is out

Dec 9, 2024 2:30pm
Close up of hallucinogenic mushrooms

Cybin psychedelic reduces depression severity after 12 months

Nov 18, 2024 12:57pm
failure crash no fail rocket cancelled end

Alto's midphase depression trial falls flat

Oct 23, 2024 4:47am
Man on chair with head in hand

Supernus links depression drug to fast responses in ph. 2 trial

Oct 18, 2024 9:17am